First Time Loading...

Cardiex Ltd
ASX:CDX

Watchlist Manager
Cardiex Ltd Logo
Cardiex Ltd
ASX:CDX
Watchlist
Price: 0.135 AUD Market Closed
Updated: Dec 11, 2023

Intrinsic Value

Valuation History
Cardiex Ltd

Historical Profit
Current Valuation
Price & Value Correlation
Value CAGR
Calculating
Intrinsic Value History...

Our system is conducting in-depth analyses to map out the stock's valuation journey. Thank you for waiting.

Fundamental Analysis

Financials
NEW
NEW

Balance Sheet Decomposition
Cardiex Ltd

Current Assets 11.6m
Cash & Short-Term Investments 716k
Receivables 7.8m
Other Current Assets 3.1m
Non-Current Assets 2.7m
Long-Term Investments 510k
PP&E 1.5m
Intangibles 633k
Other Non-Current Assets 78.6k
Current Liabilities 14.8m
Accounts Payable 7.5m
Accrued Liabilities 489k
Short-Term Debt 1.5m
Other Current Liabilities 5.4m
Non-Current Liabilities 489k
Long-Term Debt 483k
Other Non-Current Liabilities 6.2k
Efficiency
Fundamental Scores

CDX Profitability Score
Profitability Due Diligence

Cardiex Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 1-Year Revenue Growth
Positive 3-Years Revenue Growth
Declining ROE
20/100
Profitability
Score

Cardiex Ltd's profitability score is 20/100. The higher the profitability score, the more profitable the company is.

CDX Solvency Score
Solvency Due Diligence

Cardiex Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Positive Net Debt
43/100
Solvency
Score

Cardiex Ltd's solvency score is 43/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CDX Price Targets Summary
Cardiex Ltd

There are no price targets for CDX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

CDX Return Decomposition
Main factors of price return

What is price return decomposition?

CDX Price
Cardiex Ltd

1M 1M
+0%
6M 6M
-27%
1Y 1Y
-67%
3Y 3Y
-74%
5Y 5Y
-55%
10Y 10Y
-92%
Annual Price Range
0.135
52w Low
0.135
52w High
0.405
Price Metrics
Average Annual Return 33.16%
Standard Deviation of Annual Returns 61.85%
Max Drawdown -88%
Shares Statistics
Market Capitalization 19.4m AUD
Shares Outstanding 143 683 524
Percentage of Shares Shorted
N/A

Company Profile

Cardiex Ltd Logo
Cardiex Ltd

Country

Australia

Industry

Health Care

Market Cap

19.4m AUD

Dividend Yield

0%

Description

CardieX Ltd. is engaged in the designing, manufacturing, and marketing of medical devices for use in cardiovascular health management. The company is headquartered in Sydney, New South Wales. The company went IPO on 2005-11-09. The firm is focused on designing, manufacturing and marketing medical devices for use in cardiovascular health management. The company operates through its subsidiaries, including ATCOR and CONNEQT. The firm's ATCOR division provides medical devices for measuring arterial stiffness and central blood pressure waveforms based on its FDA-cleared and patented SphygmoCor technology. Under the ATCOR.X brand, the Company also develops and licenses its Arty platform consisting of physiological and health analytics for wearable devices. The firm's digital platform, ArtyNet, is a connected software as a service ecosystem providing physicians with a telehealth solution for remotely managing patients' health. CONNEQT develops and markets consumer wearable and home health devices focused on heart health and its patented fitness and wellness parameters.

Contact

NEW SOUTH WALES
Sydney
Suite 303, 15 Lime Street
+61298748761.0
https://cardiex.com/

IPO

2005-11-09

Employees

-

Officers

Co-Founder & Exec. Chairman
Mr. Niall Charles Edgar Cairns ACA, B.Ec, FAICD
Co-Founder, CEO, MD & Exec. Director
Mr. Craig R. Cooper BEC, L.L.B.
CFO, Joint Company Sec. & Exec. Director
Mr. Jarrod Travers White B.Bus, C.A., CA, CTA
Operations Director
Steve Braaten
Accounts Mang.
Carol Targos
Chief Science & Research Officer
Ahmad Qasem
Show More
Global Head of Marketing & Communications
Mr. Antony Sloan
VP of Corp. & Bus. Devel.
Mr. ZiHan Lin
Director of Sales
Ric Ruffhead
Exec. VP & Head of Global Sales for AtCor Medical Division
Mr. Douglas T. Kurschinski
Show Less

See Also

Discover More
What is the Intrinsic Value of one CDX stock?

The intrinsic value of one CDX stock under the Base Case scenario is 0.018 AUD.

Is CDX stock undervalued or overvalued?

Compared to the current market price of 0.135 AUD, Cardiex Ltd is Overvalued by 87%.